Compare Stocks: HYPD, CNTN, TONX, and DFDV

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CNTN Hillstream Biopharma	$2.29 +0.2%	$2.19	$1.75 ▼ $6.89	$181.99M	1.47	827,130 shs	378,959 shs
DFDV DeFi Development	$6.10 +3.9%	$3.48	$2.44 ▼ $18.99	$189.44M	-3.75	1.18 million shs	2.18 million shs
HYPD Hyperion DeFi	$3.55 +7.6%	$2.93	$2.34 ▼ $15.00	$55.43M	2.53	463,085 shs	1.31 million shs
TONX Verb Technology	$3.29 -1.0%	$3.13	$1.75 ▼ $8.84	$181.79M	0.72	430,522 shs	135,196 shs

7 Blue-Chip Stocks to Add To Your Forever Portfolio

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CNTN Hillstream Biopharma	0.00%	0.00%	+21.93%	-14.93%	+227,999,900.00%
DFDV DeFi Development	0.00%	+9.11%	+103.11%	+113.45%	-60.76%
HYPD Hyperion DeFi	0.00%	-3.51%	+22.22%	+27.41%	-46.25%
TONX Verb Technology	0.00%	-2.35%	+11.04%	+2.79%	+331,999,900.00%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CNTN Hillstream Biopharma	$2.29 +0.2%	$2.19	$1.75 ▼ $6.89	$181.99M	1.47	827,130 shs	378,959 shs
DFDV DeFi Development	$6.10 +3.9%	$3.48	$2.44 ▼ $18.99	$189.44M	-3.75	1.18 million shs	2.18 million shs
HYPD Hyperion DeFi	$3.55 +7.6%	$2.93	$2.34 ▼ $15.00	$55.43M	2.53	463,085 shs	1.31 million shs
TONX Verb Technology	$3.29 -1.0%	$3.13	$1.75 ▼ $8.84	$181.79M	0.72	430,522 shs	135,196 shs

7 Blue-Chip Stocks to Add To Your Forever Portfolio

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CNTN Hillstream Biopharma	0.00%	0.00%	+21.93%	-14.93%	+227,999,900.00%
DFDV DeFi Development	0.00%	+9.11%	+103.11%	+113.45%	-60.76%
HYPD Hyperion DeFi	0.00%	-3.51%	+22.22%	+27.41%	-46.25%
TONX Verb Technology	0.00%	-2.35%	+11.04%	+2.79%	+331,999,900.00%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CNTN Hillstream Biopharma	1.00	Sell	N/A	N/A
DFDV DeFi Development	2.50	Moderate Buy	$4.70	-22.94% Downside
HYPD Hyperion DeFi	2.00	Hold	$7.78	118.95% Upside
TONX Verb Technology	1.00	Sell	N/A	N/A

Current Analyst Ratings Breakdown

Latest HYPD, CNTN, TONX, and DFDV Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/8/2026	HYPD Hyperion DeFi	Chardan Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$7.30 ➝ $8.45
9/1/2026	HYPD Hyperion DeFi	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (D) ➝ Sell (D+)
8/25/2026	CNTN Hillstream Biopharma	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
8/18/2026	HYPD Hyperion DeFi	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (D-) ➝ Sell (D)
8/13/2026	HYPD Hyperion DeFi	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$6.60 ➝ $7.10
8/12/2026	HYPD Hyperion DeFi	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold ➝ Strong Sell
8/11/2026	HYPD Hyperion DeFi	Chardan Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$7.30
7/17/2026	DFDV DeFi Development	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Hold (C)
7/15/2026	CNTN Hillstream Biopharma	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
7/14/2026	HYPD Hyperion DeFi	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Strong Sell ➝ Hold
7/6/2026	TONX Verb Technology	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)

(Data available from 9/8/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CNTN Hillstream Biopharma	N/A	N/A	N/A	N/A	$10.92 per share	N/A
DFDV DeFi Development	$11.39M	16.60	$0.92 per share	6.60	$3.12 per share	1.95
HYPD Hyperion DeFi	$810K	68.13	N/A	N/A	$4.73 per share	0.75
TONX Verb Technology	$12.78M	14.16	N/A	N/A	$6.88 per share	0.48

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CNTN Hillstream Biopharma	-$35.92M	-$0.50	N/A	N/A	N/A	N/A	-20.06%	-15.90%	N/A
DFDV DeFi Development	-$73.79M	-$9.98	N/A	N/A	N/A	-1,319.45%	17.97%	5.02%	N/A
HYPD Hyperion DeFi	-$45.31M	-$6.53	N/A	3.32	N/A	416.56%	-11.62%	-9.96%	N/A
TONX Verb Technology	-$148.48M	-$1.04	N/A	N/A	N/A	-497.15%	-60.82%	-59.56%	N/A

Latest HYPD, CNTN, TONX, and DFDV Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
8/13/2026	Q2 2026	HYPD Hyperion DeFi	N/A	$0.92	N/A	$0.92	N/A	$0.36 million
8/12/2026	Q2 2026	DFDV DeFi Development	N/A	-$0.21	N/A	-$1.00	N/A	$3.31 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
CNTN Hillstream Biopharma	N/A	N/A	N/A	N/A	N/A
DFDV DeFi Development	N/A	N/A	N/A	N/A	N/A
HYPD Hyperion DeFi	N/A	N/A	N/A	N/A	N/A
TONX Verb Technology	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CNTN Hillstream Biopharma	N/A	15.70	15.70
DFDV DeFi Development	12.53	1.27	1.27
HYPD Hyperion DeFi	0.06	2.34	2.34
TONX Verb Technology	N/A	6.39	6.39

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CNTN Hillstream Biopharma	1.16%
DFDV DeFi Development	0.48%
HYPD Hyperion DeFi	25.84%
TONX Verb Technology	7.24%

Insider Ownership

Company	Insider Ownership
CNTN Hillstream Biopharma	3.34%
DFDV DeFi Development	23.61%
HYPD Hyperion DeFi	7.50%
TONX Verb Technology	21.43%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CNTN Hillstream Biopharma	2	79.68 million	77.02 million	N/A
DFDV DeFi Development	N/A	31.00 million	23.68 million	N/A
HYPD Hyperion DeFi	40	15.54 million	14.37 million	No Data
TONX Verb Technology	170	55.07 million	43.27 million	N/A

HYPD, CNTN, TONX, and DFDV Headlines

Recent News About These Companies

TON Strategy Company Highlights TON Upgrade Establishing Network-Level Infrastructure for Telegram's Native Gram Wallet

September 1, 2026 | globenewswire.com

TON Strategy Company Appoints Oscar Suarez to Board of Directors and Names Him Audit Committee Chair

August 17, 2026 | globenewswire.com

Insider Buying: Verb Technology (NASDAQ:TONX) CEO Buys 3,700 Shares of Stock

August 15, 2026 | insidertrades.com

TON Strategy Company (TONX) Q2 2026 Earnings Call Transcript

August 11, 2026 | seekingalpha.com

TON Strategy Company Sets Second Quarter 2026 Conference Call for Tuesday, August 11, 2026 at 9:00 a.m. ET

July 28, 2026 | globenewswire.com

TON Strategy Company Highlights Continued Infrastructure Advancements Across the TON Ecosystem

July 22, 2026 | globenewswire.com

TON Strategy Company Provides Update on Wind-Down of Legacy Operations and June Staking Performance

July 16, 2026 | globenewswire.com

TON Strategy Company Advances Share Repurchase Program

July 1, 2026 | globenewswire.com

TON Strategy Company Highlights Toncoin Rebrand to Gram as TON Ecosystem Advances Telegram-Native Currency Identity

June 15, 2026 | globenewswire.com

TON Strategy Company Highlights Strong May Staking Performance and Approved TON Network Upgrades

June 8, 2026 | globenewswire.com

TON Strategy Company Highlights Launch of Acton Developer Toolchain for the TON Ecosystem

May 19, 2026 | globenewswire.com

Sarah Josephine Olsen Buys 7,440 Shares of Verb Technology (NASDAQ:TONX) Stock

May 15, 2026 | insidertrades.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

HYPD, CNTN, TONX, and DFDV Company Descriptions

Hillstream Biopharma NASDAQ:CNTN

$2.28 +0.01 (+0.22%)

As of 02:27 PM Eastern

Hillstream BioPharma, Inc., a pre-clinical biotechnology company, develops novel therapeutic candidates targeting ferroptosis, an anti-cancer mechanism resulting in iron mediated cell death (IMCD) for the treatment resistant cancers. The company's product candidate is HSB-1216, an IMCD inducer targeting solid tumors. It also develops HSB-888, a dual Quatramer loaded IMCD inducer coupled with its anthracycline analogue for solid tumors; HSB-510, a targeted bifunctional inhibitory compound in Quatramer with single digit nanomolar; IC50 against PI3K-delta and HDAC6, which is also known to downregulate; c-myc, a cancer drug target; and HSB-114, an immunotherapeutic agent, which uses its Quatramer technology to deliver tumor necrosis factor-alpha gene into cancer cells. The company was incorporated in 2019 and is based in Bridgewater, New Jersey.

DeFi Development NASDAQ:DFDV

$6.10 +0.23 (+3.90%)

As of 02:28 PM Eastern

We are a B2B fintech marketplace connecting commercial property borrowers and lenders with a human touch. We seek to revolutionize the commercial real estate lending market by making it hyper-efficient, transparent, and accessible to all rather than the few. Through our online platform, we provide technology that connects commercial mortgage borrowers looking for capital to refinance, build, or purchase commercial property, including, but not limited to, apartment buildings, to commercial property lenders. Borrowers include, but are not limited to, owners, operators, and developers of commercial real estate including multifamily properties and most recently, a growing segment of small business owners, which we believe represents a significant growth opportunity. Lenders include small banks, credit unions, REITs, Fannie Mae® and Freddie Mac® multifamily lenders, FHA® multifamily lenders, debt funds, CMBS lenders, SBA lenders, and more. We have developed a flexible, two-sided, B2B marketplace that connects commercial borrowers and lenders, with a human touch. Commercial property owners, operators, and developers can quickly create an account on our platform, set up their own profile, and submit and manage loan requests on their dashboard in a digital experience. Our algorithms automatically match borrowers to their best loan options or to our internal capital markets advisors that guide the borrower throughout the process and connect them with a potentially suitable loan product and lender. Originators that work at commercial mortgage lenders can access their accounts on our platform to view, sort, and communicate with their matched borrowers in real-time, tracking their loan progress through our portal. Capital markets advisors that work internally have their own interface that gives them access to targeted loan opportunities empowering them to better assist borrowers in managing their choices, leading to the best possible outcomes for both lenders and borrowers while building trust, all of which is intended to enhance our brand. We believe that as we scale, we can use the same technology to provide similar services across the commercial property and small business value chain. Our mission is to remove frictions from traditional commercial property financing, making it easier and more cost-effective for all parties in the transaction. We intend to disintermediate commercial real estate financing, flattening the playing field for commercial property owners and developers, and lenders of all sizes, democratizing an otherwise fractured and elitist market. We were originally formed as Janover Ventures LLC, a Florida limited liability company, on November 28, 2018, and converted to Janover Inc., a Delaware corporation, on March 9, 2021. We are headquartered at 6401 Congress Avenue, Suite 250, Boca Raton, Florida.

Hyperion DeFi NASDAQ:HYPD

$3.55 +0.25 (+7.61%)

As of 02:27 PM Eastern

Eyenovia, Inc., an ophthalmic technology company, engages in the development of therapeutics based on its proprietary microdose array print platform technology. The company's product candidates include MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; and Mydcombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis. It has a license agreement with Bausch Health Ireland Limited to develop and commercialize MicroPine in the United States and Canada; a license agreement with Arctic Vision (Hong Kong) Limited to develop and commercialize MicroPine, MicroLine, and Mydcombi in China and South Korea; and Senju Pharmaceutical Co., Ltd. to develop and commercialize MicroPine, MicroLine, and Mydcombi. The company was formerly known as PGP Holdings V, Inc. and changed its name to Eyenovia, Inc. in May 2014. Eyenovia, Inc. was incorporated in 2014 and is based in New York, New York.

Verb Technology NASDAQ:TONX

$3.29 -0.03 (-0.99%)

As of 02:27 PM Eastern

Verb Technology Company, Inc. develops Software-as-a-Service applications platform in the United States, Japan, and internationally. It offers verbCRM, a customer relationship management (CRM) application; verbTEAMS, a CRM application for small and medium-sized businesses and solopreneurs; verbLEARN, a learning management system application that incorporates clickable in-video technology featured in its verbCRM application; and verbLIVE, a live eCommerce application. The company also provides non-digital services to enterprise clients, such as design and printing services for welcome and starter kits; fulfilment services, which include managing the preparation, handling, and shipping of custom-branded merchandise; and subscription-based application services. It serves large enterprises in the life sciences sector, professional sports franchises, educational institutions, and not-for-profit organizations, as well as clients in the entertainment industry and the burgeoning CBD industry, among other business sectors. The company was formerly known as nFüsz, Inc. and changed its name to Verb Technology Company, Inc. in February 2019. Verb Technology Company, Inc. was founded in 2012 and is based in American Fork, Utah.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest HYPD, CNTN, TONX, and DFDV Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest HYPD, CNTN, TONX, and DFDV Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

HYPD, CNTN, TONX, and DFDV Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

HYPD, CNTN, TONX, and DFDV Company Descriptions

Hillstream Biopharma NASDAQ:CNTN

DeFi Development NASDAQ:DFDV

Hyperion DeFi NASDAQ:HYPD

Verb Technology NASDAQ:TONX

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest HYPD, CNTN, TONX, and DFDV Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest HYPD, CNTN, TONX, and DFDV Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

HYPD, CNTN, TONX, and DFDV Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

HYPD, CNTN, TONX, and DFDV Company Descriptions

Hillstream Biopharma NASDAQ:CNTN

DeFi Development NASDAQ:DFDV

Hyperion DeFi NASDAQ:HYPD

Verb Technology NASDAQ:TONX

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools